NCT07788638 Non-Invasive Neurofeedback Training to Alleviate Tinnitus Distress
| NCT ID | NCT07788638 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Urbana-Champaign |
| Condition | Tinnitus Aggravated |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-08-12 |
| Primary Completion | 2026-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-08-12 with a primary completion date of 2026-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The broad goals of this project are to apply and validate the therapeutic utility of neurofeedback-guided intervention for tinnitus and its associated psychological sufferings. In this project, the investigators will evaluate whether targeted (non-auditory networks) neurofeedback-based training can restore emotional and cognitive health for individuals with bothersome tinnitus. The investigators will also link individual tinnitus scores with objective brain imaging measures before, during, and after the intervention. The investigators will accomplish these goals by using a combined brain imaging and behavioral experimental framework.
Eligibility Criteria
Inclusion Criteria: * Non-pulsatile tinnitus for at least 6 months, * Bothersome tinnitus, based on a Tinnitus Functional Index score \> 25, * Normal cognitive processing abilities, based on a Montreal Cognitive Assessment score\> 25. Exclusion Criteria: * Clinically diagnosed dementia or Parkinson's disease, * Meniere's disease, * Severe physical or cognitive impairments that prevent completion of study tasks or scanning, * History of drug or alcohol abuse, * History of psychological or neurological illness, except for managed anxiety or depression, * Severe chronic health problems other than hearing loss or tinnitus, * Vision that is not normal or not corrected to normal, * Unable to meet MRI clinical safety screening requirements (e.g., metal in the body, pregnancy, certain implantable devices).
Contact & Investigator
Fatima T Husain, PhD
PRINCIPAL INVESTIGATOR
University of Illinois Urbana-Champaign
Frequently Asked Questions
Who can join the NCT07788638 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Tinnitus Aggravated. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07788638 currently recruiting?
Yes, NCT07788638 is actively recruiting participants. Contact the research team at tinnitus-ACNLab@illinois.edu for enrollment information.
Where is the NCT07788638 trial being conducted?
This trial is being conducted at Urbana, United States.
Who is sponsoring the NCT07788638 clinical trial?
NCT07788638 is sponsored by University of Illinois at Urbana-Champaign. The principal investigator is Fatima T Husain, PhD at University of Illinois Urbana-Champaign. The trial plans to enroll 20 participants.